carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
January Generic Drug Releases
Released: 01/09/2012
By: Theron Mindek

Generic Ritalin LA® Capsules Launched

Actavis Group commenced shipping their AB rated generic equivalent of Novartis' Ritalin LA® Capsules in the 20, 30, and 40mg strengths (100-count bottle).
Ritalin LA® (methylphenidate hydrochloride) extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
This drug is classified as a CII medication. New prescriptions (hard copies) will be required at the pharmacy in order to dispense the new generic version.

Generic Clobex® Lotion and Shampoo Launched

Actavis Group commenced shipping their AB rated generic equivalent of Clobex® (Clobetasol) lotion and shampoo 0.05% in the 2 and 4 ounce sizes for the lotion, and 4 ounce size for the shampoo.
Clobex® (clobetasol propionate) Shampoo, 0.05% is a super-high potent topical corticosteroid formulation indicated for the treatment of moderate to severe forms of scalp psoriasis in subjects 18 years of age and older.

Authorized Generic of Ryzolt® Tablets Launched

Rhodes Pharmaceuticals launched tramadol hydrochloride extended-release tablets, the authorized generic (AG) of Purdue Pharma’s branded product, Ryzolt®.
Ryzolt® (tramadol hydrochloride) is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

All generics are in stock and available to all claimants covered by Carlisle Medical Home Delivery Pharmacy.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer